How did Synthetic Biologics, Inc. (NYSE American: SYN) climb during premarket?

DBGI Stock

Clinical-stage company Synthetic Biologics, Inc. (NYSE American: SYN) develops therapeutics for gastrointestinal diseases. Its lead product candidates include SYN-004 that has completed Phase II clinical studies designed to degrade commonly used intravenous beta-lactam antibiotics that have been in use for years. Recent Performance In the recent session Company’s stock finished up 30.57% to $0.50. During […]

BMO Capital lifts Avery Dennison [AVY] rating to Outperform and price target to $184

MTTR

BMO Capital took its Avery Dennison [AVY] rating to the equivalent of Outperform from Market ‎Perform, and the price target to $184, in a research note dated 2021-01-05. That figure represents ‎around a 21.16% premium from where the company’s shares closed on Monday. Other analysts also ‎revised their coverage, with JP Morgan’s analysts upgrading the […]

Deutsche bank raises Dine Brands Global [DIN]’s rating to Buy and price target to $77

MTTR

Deutsche bank took its Dine Brands Global [DIN] rating to the equivalent of Buy from Hold, and the ‎price target to $77, in a research note dated 2021-01-05. That figure represents around a 33.75% ‎premium from where the company’s shares closed on Monday. Other analysts also revised their ‎coverage, with MKM Partners’s analysts downgrading the […]

JD.com [JD] Upgraded to Buy at Stifel with $‎105 price target

DNAY Stock

Stifel took its JD.com [JD] rating to the equivalent of Buy from Hold, and the price target to $105 from, ‎in a research note dated 2021-01-05. That figure represents around a 21.63% premium from where the ‎company’s shares closed on Monday. Other analysts also revised their coverage, with Macquarie’s ‎analysts upgrading the shares from “a […]

KeyBanc lifts Cadence Design Systems [CDNS] rating to Overweight and price target to $155

XRTX

KeyBanc took its Cadence Design Systems [CDNS] rating to the equivalent of Overweight from Sector ‎Weight, and the price target to $155, in a research note dated 2021-01-05. That figure represents ‎around a 14.17% premium from where the company’s shares closed on Monday. Some new analysts ‎also started their coverage, with UBS’s analysts assigning the […]

KeyBanc maintains Welbilt [WBT] at Overweight rating with an $18 price target

SPRO Stock

KeyBanc maintained its Welbilt [WBT] rating to the equivalent of Overweight but changed the price ‎target to $18, in a research note dated 2021-01-05. That figure represents around a 43.2% premium ‎from where the company’s shares closed on Monday. Meanwhile, Buckingham Research had lowered ‎its rating on WBT to “Neutral” from the earlier “Buy”, in […]

Piper Sandler raises DocuSign Inc. [DOCU]’s rating to Overweight and price target to $300

Piper Sandler took its DocuSign [DOCU] rating to the equivalent of Overweight from Neutral, and the ‎price target to 300.0, in a research note dated 2021-01-05. That figure represents around a 34.89% ‎premium from where the company’s shares closed on Monday. Some new analysts also started their ‎coverage, with Needham’s analysts assigning the shares to […]

What to Expect When MSC Industrial Direct Co. Inc. [MSM] Reports Quarterly Earnings

DBGI Stock

MSC Industrial Direct Co. Inc. [NYSE:MSM] will report earnings after markets close on Wednesday, ‎January 6th. Get the hottest stocks to ‎trade every day before the market opens 100% free. Click here now.  MSM Earnings Forecast For The Current Quarter MSC Industrial Direct Co. Inc. ‎‎[MSM] is expected to report weak earnings results for the […]

Belgium to Obtain Partial Delivery of Pfizer vaccine As Germany tightened the Lockdown

DNAY Stock

A logistical problem that arose last month meant that Belgium would obtain only half of the doses of vaccine it requested for January from the pharmaceutical company Pfizer. A spokesman for the Health Ministry, Yves Van Laethem, reported that logistical issues in the second half of December prevented the supply of Covid vaccines as expected […]

Piper Sandler cuts Okta Inc. [OKTA]’s rating to Neutral

MRAI Stock

Piper Sandler took its Okta [OKTA] rating to the equivalent of Neutral from Overweight, in a research ‎note dated 2021-01-05. Some new analysts also started their coverage, with RBC Capital Mkts’s ‎analysts assigning the shares to “an Outperform” rating in a research note to investors issued in early ‎July. Meanwhile, BTIG Research had lowered its […]